Document is current
Any future updates will be listed below
-
Authors
Kung, Yu-Jui
Lam, Brandon
Tseng, Ssu-Hsueh
MacDonald, Alana
Tu, Hsin-Fang
Wang, Suyang
Lin, John
Tsai, Ya Chea
Wu, T. C.
Hung, Chien-Fu https://orcid.org/0000-0001-9170-7797
-
Funding
Funding for this research was provided by:
National Cancer Institute (R21DE029910)
National Institutes of Health (R01CA237067, R21CA234516, R21CA256020, 5F31CA236051)
- License Information
-
More Information
Article History
Received: 1 February 2022
Accepted: 3 August 2022
First Online: 12 August 2022
Declarations
:
: Not applicable.
: Not applicable.
: Dr. Wu is a co-founder of and has an equity ownership interest in Papivax LLC. Also, he owns Papivax Biotech Inc. stock options and is a member of Papivax Biotech Inc.’s Scientific Advisory Board. Additionally, under a licensing agreement between Papivax Biotech Inc. and the Johns Hopkins University, Dr. Wu is entitled to royalties on an invention described in this article. This arrangement has been reviewed and approved by the Johns Hopkins University in accordance with its conflict of interest policies.
